A smartphone app developed by Otsuka and digital health firm Click Therapeutics has been launched in Great Britain – its ...

NHS cost-effectiveness overseer NICE has published new guidance recommending IL-36 inhibitor Spevigo (spesolimab) for the ...

The PMS requirement applies to all UKCA- and CE-marked devices, like in vitro diagnostics (IVDs), glucose monitors, and ...

The financing has been billed as the most significant commercial investment into Welsh research to date, and will help Draig ...

The Commissioner's National Priority Voucher (CNPV) programme will be available to companies aligned with pressing matters ...

FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national ...

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply ...

Published in the Journal of the American Medical Association (JAMA), the letter says that the dismissal of the advisors and the appointment of eight new ACIP members two days later, along with ...

Eli Lilly has confirmed plans for a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the ...

Liver damage is a well-recognised complication of gene therapies based on adeno-associated virus (AAV) vectors, and other ...

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Factor XIIa inhibitor Andembry (garadacimab) has been cleared in the US for use in patients aged 12 and over with HAE, which ...